Beijing Wantai Biological Pharmacy Enterprise Co Ltd - ESG Rating & Company Profile powered by AI
The page contains a zero-cost ESG assessment covering Beijing Wantai Biological Pharmacy Enterprise Co Ltd. The ESG score includes 17 United Nations SDGs including: 'Zero Hunger', 'Industry, Innovation & Infrastructure' and 'Partnerships for the Goals'. Browse to the end of the webpage for potential risks for Beijing Wantai Biological Pharmacy Enterprise Co Ltd based on sector, geography and size.
Beijing Wantai Biological Pharmacy Enterprise Co Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1967 | Hospira Inc | 0.3 | Low |
1967 | PRA Health Sciences Inc | 0.3 | Low |
1970 | Beijing Wantai Biological Pharmacy Enterprise Co Ltd | 0.0 | Low |
1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CTC Bio Inc | 0.0 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Beijing Wantai Biological Pharmacy Enterprise Co Ltd have an accelerator or VC vehicle to help deliver innovation?
Does Beijing Wantai Biological Pharmacy Enterprise Co Ltd disclose current and historical energy intensity?
Does Beijing Wantai Biological Pharmacy Enterprise Co Ltd report the average age of the workforce?
Does Beijing Wantai Biological Pharmacy Enterprise Co Ltd reference operational or capital allocation in relation to climate change?
Does Beijing Wantai Biological Pharmacy Enterprise Co Ltd disclose its ethnicity pay gap?
Does Beijing Wantai Biological Pharmacy Enterprise Co Ltd disclose cybersecurity risks?
Does Beijing Wantai Biological Pharmacy Enterprise Co Ltd offer flexible work?
Does Beijing Wantai Biological Pharmacy Enterprise Co Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Beijing Wantai Biological Pharmacy Enterprise Co Ltd disclose the number of employees in R&D functions?
Does Beijing Wantai Biological Pharmacy Enterprise Co Ltd conduct supply chain audits?
Does Beijing Wantai Biological Pharmacy Enterprise Co Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Beijing Wantai Biological Pharmacy Enterprise Co Ltd conduct 360 degree staff reviews?
Does Beijing Wantai Biological Pharmacy Enterprise Co Ltd disclose the individual responsible for D&I?
Does Beijing Wantai Biological Pharmacy Enterprise Co Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Beijing Wantai Biological Pharmacy Enterprise Co Ltd disclose current and / or historical scope 2 emissions?
Does Beijing Wantai Biological Pharmacy Enterprise Co Ltd disclose water use targets?
Does Beijing Wantai Biological Pharmacy Enterprise Co Ltd have careers partnerships with academic institutions?
Did Beijing Wantai Biological Pharmacy Enterprise Co Ltd have a product recall in the last two years?
Does Beijing Wantai Biological Pharmacy Enterprise Co Ltd disclose incidents of discrimination?
Does Beijing Wantai Biological Pharmacy Enterprise Co Ltd allow for Work Councils/Collective Agreements to be formed?
Has Beijing Wantai Biological Pharmacy Enterprise Co Ltd issued a profit warning in the past 24 months?
Does Beijing Wantai Biological Pharmacy Enterprise Co Ltd disclose parental leave metrics?
Does Beijing Wantai Biological Pharmacy Enterprise Co Ltd disclose climate scenario or pathway analysis?
Does Beijing Wantai Biological Pharmacy Enterprise Co Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Beijing Wantai Biological Pharmacy Enterprise Co Ltd disclose the pay ratio of women to men?
Does Beijing Wantai Biological Pharmacy Enterprise Co Ltd support suppliers with sustainability related research and development?
Does Beijing Wantai Biological Pharmacy Enterprise Co Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Beijing Wantai Biological Pharmacy Enterprise Co Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Beijing Wantai Biological Pharmacy Enterprise Co Ltd involved in embryonic stem cell research?
Does Beijing Wantai Biological Pharmacy Enterprise Co Ltd disclose GHG and Air Emissions intensity?
Does Beijing Wantai Biological Pharmacy Enterprise Co Ltd disclose its waste policy?
Does Beijing Wantai Biological Pharmacy Enterprise Co Ltd report according to TCFD requirements?
Does Beijing Wantai Biological Pharmacy Enterprise Co Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Beijing Wantai Biological Pharmacy Enterprise Co Ltd disclose energy use targets?
Does Beijing Wantai Biological Pharmacy Enterprise Co Ltd disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Beijing Wantai Biological Pharmacy Enterprise Co Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for Beijing Wantai Biological Pharmacy Enterprise Co Ltd
These potential risks are based on the size, segment and geographies of the company.
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. researches, develops, produces, distributes, and sells infectious disease diagnostic reagents and vaccines in China and internationally. The company provides COVID 19, HIV and HTLV, Hepatitis, EV-71, and Tuberculosis diagnostics test kits; Hepatitis C and Syphilis detection reagents; automated immunoassays; ELISA kits and rapid tests for infectious disease diagnostics; chemiluminescence and clinical chemistry reagents; immunodiagnostic reagents; and Hepatitis E and human papillomavirus vaccines. It serves blood banks, hospitals and clinics, reference laboratories, border inspection centers, blood-processing companies, and research institutes. The company was founded in 1991 and is headquartered in Beijing, China.